Diosmin
Sponsors
Laboratoire Innotech International, Benha University, Ain Shams University, Pirogov Russian National Research Medical University, Fundação Educacional Serra dos Órgãos
Conditions
Chronic Venous Disease of Lower LimbsDeep Vein ThrombosisDigital UlcerInfertilityMenorrhagiaNon Alcoholic SteatohepatitisNon-bleeding Peptic UlcerPostthrombotic Syndrome
Phase 1
Phase 2
Phase 3
Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs
CompletedNCT01532882
Start: 2012-01-31End: 2013-04-30Updated: 2013-04-29
the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis
NCT05626166
Start: 2022-12-15End: 2024-11-30Target: 60Updated: 2023-04-12
Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer
NCT05670457
Start: 2022-06-30End: 2025-06-30Target: 44Updated: 2023-01-04
the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.
NCT05942547
Start: 2023-07-10End: 2025-06-10Target: 48Updated: 2023-07-12
Phase 4
Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
CompletedNCT03413618
Start: 2017-12-20End: 2019-07-31Updated: 2021-02-04
Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency
CompletedNCT03471910
Start: 2017-06-20End: 2018-04-30Updated: 2018-06-20